nirogacestat
Showing 1 - 12 of 12
Desmoid Tumor Trial in Palo Alto (Nirogacestat, Cryoablation)
Not yet recruiting
- Desmoid Tumor
- Nirogacestat
- Cryoablation
-
Palo Alto, CaliforniaStanford University
Jul 7, 2023
Tumor Trial in Houston (Nirogacestat)
Not yet recruiting
- Tumor
- Nirogacestat
-
Houston, TexasM D Anderson Cancer Center
May 18, 2023
Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- +7 more
- Belantamab Mafodotin-Blmf
- +3 more
- (no location specified)
Oct 11, 2022
Multiple Myeloma Trial in United States (Belantamab Mafodotin, Nirogacestat)
Recruiting
- Multiple Myeloma
- Belantamab Mafodotin
- Nirogacestat
-
Basking Ridge, New Jersey
- +6 more
Oct 5, 2022
Multiple Myeloma Trial in United States (Belantamab Mafodotin, Nirogacestat)
Not yet recruiting
- Multiple Myeloma
- Belantamab Mafodotin
- Nirogacestat
-
Basking Ridge, New Jersey
- +6 more
Mar 2, 2022
Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor, Ovarian Cancer Trial in Canada, Poland, United States
Recruiting
- Ovarian Granulosa-Stromal Tumor
- +2 more
- Nirogacestat
-
Los Angeles, California
- +20 more
Jul 13, 2022
Relapsed/Refractory Multiple Myeloma Trial in United States (PBCAR269A, Fludarabine, Cyclophosphamide)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- PBCAR269A
- +3 more
-
Duarte, California
- +4 more
Jun 24, 2021
Relapsed/Refractory Multiple Myeloma Trial in United States (genetic, biological, drug)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- ALLO-715
- +4 more
-
Gilbert, Arizona
- +11 more
Feb 18, 2022
Desmoid Fibromatosis, Recurrent Desmoid Fibromatosis, Unresectable Desmoid Fibromatosis Trial in Worldwide (Nirogacestat,
Active, not recruiting
- Desmoid Fibromatosis
- +2 more
- Nirogacestat
- +2 more
-
Birmingham, Alabama
- +95 more
Dec 13, 2022
Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- Teclistamab
- +5 more
-
Birmingham, Alabama
- +26 more
Jan 17, 2023
Relapsed/Refractory Multiple Myeloma Trial in Worldwide (ABBV-383, Dexamethasone, Lenalidomide)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- ABBV-383
- +5 more
-
Little Rock, Arkansas
- +45 more
Jul 8, 2022